Elena N. Kalemberg
Elena N. Kalemberg has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Karapet V. Davtyan
National Medical Research Center for Therapy and Preventive Medicine of the Ministry of Health of the Russian Federation
8 shared publications - A. A. Brutyan
National Medical Research Center for Therapy and Preventive Medicine
7 shared publications - Maria Sergeevna Kharlap
National Medical Research Center for Therapy and Preventive Medicine of the Ministry of Health of the Russian Federation
6 shared publications - A. G. Topchyan
National Medical Research Center for Therapy and Preventive Medicine, Moscow, Russia
5 shared publications - Aishat A. Abdullaeva
National Medical Research Center for Therapy and Preventive Medicine of the Ministry of Health of the Russian Federation
3 shared publications - Andrey A. Kalemberg
M. F. Vladimirsky Moscow Regional Research Clinical Institute, Moscow, 129110, Russia
3 shared publications
Latest Publications
- Open Access
- 13 June 2026
- Published by Institute of Cardio Technics - INCART in Journal of Arrhythmology
- Vol. 33 (2) , 14-21
Correlation between pulmonary vein isolation efficacy and myocardial morphological changes
Aim . To investigate the correlation between the efficacy of pulmonary vein ostial isolation and morphological changes in the myocardium. Methods . The study included 118 patients with paroxysmal or persistent atrial fibrillation (AF) and no significant structural heart disease. All patients underwent primary cryoballoon isolation of the pulmonary vein ostia with simultaneous implantation of a loop ECG recorder (Medtronic Reveal XT) and myocardial biopsy of the interatrial septum (IAS) and the interventricular septum (IVS). Tissue samples were obtained before cryoballoon ablation (CBA). Patients were followed for one year with regular visits at 3, 6, and 12 months. If AF recurred, patients underwent a repeat electrophysiological study to assess the durability of pulmonary vein isolation. In cases of recovered pulmonary vein conduction, reisolation was performed, followed by another year of followup using the same visit schedule. Consequently, two patient groups were formed: those without AF recurrence (after one or two procedures) and those with recurrence (after two catheter isolation attempts). Results . Owing to an insufficient number of representative IAS biopsy samples (the biopsy material mainly consisted of the fibrous portion of the IAS), the analysis of the relationship between IAS morphological changes and nonpulmonaryveindependent AF recurrence could not be performed. In IVS biopsy samples, the most common morphological findings were myocardial hypertrophy, loss of myocardial crossstriation, endocardial thickening and lipomatosis, and cardiomyocyte dystrophy. Conclusion . In all AF patients without severe organic heart disease, various morphological changes of the IVS myocardium were identified, including fibrosis, lipomatosis, and dystrophy. Histological changes in myocardial biopsies from AF patients, such as cardiomyocyte degeneration and endocardial thickening, are important components of atrial remodelling that contribute to arrhythmia initiation, maintenance, and progression - consistent with the concept of atrial cardiomyopathy (atrial myopathy) regardless of its origin. A deeper understanding of these cellular and molecular changes may inform the development of novel targeted strategies for AF prevention and treatment. No clear predictors of a specific electrophysiological type of AF recurrence (pulmonaryveindependent vs. nonpulmonaryveindependent) after radiofrequency ablation were identified, which may reflect common underlying mechanisms and warrants further investigation.
- 13 June 2026
- Published by Institute of Cardio Technics - INCART in Journal of Arrhythmology
- Vol. 33 (2) , 14-21
Open AccessCorrelation between pulmonary vein isolation efficacy and myocardial morphological changes
Aim . To investigate the correlation between the efficacy of pulmonary vein ostial isolation and morphological changes in the myocardium. Methods . The study included 118 patients with paroxysmal or persistent atrial fibrillation (AF) and no significant structural heart disease. All patients underwent primary cryoballoon isolation of the pulmonary vein ostia with simultaneous implantation of a loop ECG recorder (Medtronic Reveal XT) and myocardial biopsy of the interatrial septum (IAS) and the interventricular septum (IVS). Tissue samples were obtained before cryoballoon ablation (CBA). Patients were followed for one year with regular visits at 3, 6, and 12 months. If AF recurred, patients underwent a repeat electrophysiological study to assess the durability of pulmonary vein isolation. In cases of recovered pulmonary vein conduction, reisolation was performed, followed by another year of followup using the same visit schedule. Consequently, two patient groups were formed: those without AF recurrence (after one or two procedures) and those with recurrence (after two catheter isolation attempts). Results . Owing to an insufficient number of representative IAS biopsy samples (the biopsy material mainly consisted of the fibrous portion of the IAS), the analysis of the relationship between IAS morphological changes and nonpulmonaryveindependent AF recurrence could not be performed. In IVS biopsy samples, the most common morphological findings were myocardial hypertrophy, loss of myocardial crossstriation, endocardial thickening and lipomatosis, and cardiomyocyte dystrophy. Conclusion . In all AF patients without severe organic heart disease, various morphological changes of the IVS myocardium were identified, including fibrosis, lipomatosis, and dystrophy. Histological changes in myocardial biopsies from AF patients, such as cardiomyocyte degeneration and endocardial thickening, are important components of atrial remodelling that contribute to arrhythmia initiation, maintenance, and progression - consistent with the concept of atrial cardiomyopathy (atrial myopathy) regardless of its origin. A deeper understanding of these cellular and molecular changes may inform the development of novel targeted strategies for AF prevention and treatment. No clear predictors of a specific electrophysiological type of AF recurrence (pulmonaryveindependent vs. nonpulmonaryveindependent) after radiofrequency ablation were identified, which may reflect common underlying mechanisms and warrants further investigation.
- Open Access
- 9 January 2026
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 13 (1) , 39
Atrial Fibrillation Recurrence After Catheter Ablation Is Associated with TAG72 Protein
Despite the efficacy of catheter ablation in preventing recurrences of atrial fibrillation (AF), the reasons for its lack of success in some patients remain unknown. The aim of this study was to try to identify a new predictor of AF recurrence following catheter-based treatment. This prospective study enrolled a cohort of patients with AF. Based on the results of a one-year follow-up, patients were divided into two groups: Group 1 (“vein-dependent” AF)—patients who achieved a successful outcome after 1–2 catheter ablation procedures—and Group 2 (“non-vein-dependent” AF)—patients with confirmed complete pulmonary vein isolation (PVI) or with an identified “non-vein-dependent” AF substrate. Blood samples were collected prior to the procedure and biobanked. Initial proteomic profiling of the serum using protein microarrays identified several candidate proteins, whose elevated levels were subsequently confirmed by an enzyme-linked immunosorbent assay (ELISA). This article presents data on one such protein—TAG72. A comparison of TAG72 levels (%OD normalized units) between Group 1 (“vein-dependent” AF) and Group 2 (“non-vein-dependent” AF) revealed a statistically significant increase in the latter group (128.9 [98.2; 284.4] vs. 84.3 [73.8; 92.1], p < 0.001). These data provide the first evidence implicating TAG72 in the pathogenesis of AF.
- 9 January 2026
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 13 (1) , 39
Open AccessAtrial Fibrillation Recurrence After Catheter Ablation Is Associated with TAG72 Protein
Despite the efficacy of catheter ablation in preventing recurrences of atrial fibrillation (AF), the reasons for its lack of success in some patients remain unknown. The aim of this study was to try to identify a new predictor of AF recurrence following catheter-based treatment. This prospective study enrolled a cohort of patients with AF. Based on the results of a one-year follow-up, patients were divided into two groups: Group 1 (“vein-dependent” AF)—patients who achieved a successful outcome after 1–2 catheter ablation procedures—and Group 2 (“non-vein-dependent” AF)—patients with confirmed complete pulmonary vein isolation (PVI) or with an identified “non-vein-dependent” AF substrate. Blood samples were collected prior to the procedure and biobanked. Initial proteomic profiling of the serum using protein microarrays identified several candidate proteins, whose elevated levels were subsequently confirmed by an enzyme-linked immunosorbent assay (ELISA). This article presents data on one such protein—TAG72. A comparison of TAG72 levels (%OD normalized units) between Group 1 (“vein-dependent” AF) and Group 2 (“non-vein-dependent” AF) revealed a statistically significant increase in the latter group (128.9 [98.2; 284.4] vs. 84.3 [73.8; 92.1], p < 0.001). These data provide the first evidence implicating TAG72 in the pathogenesis of AF.
- Open Access
- 26 September 2025
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 25 (1) , 1-6
Does cryoballoon ablation affect the symptom severity of atrial fibrillation? Insights from 12-months continuous cardiac monitoring
Most data on asymptomatic atrial fibrillation (AF) recurrence following catheter ablation primarily derive from studies on radiofrequency ablation (RFA). Our previous study with a small sample size revealed no significant difference in AF freedom rates detected via patient history, ECG, Holter monitoring, and continuous cardiac monitoring in the cryoballoon ablation (CBA) group. This study aims to evaluate alterations in AF symptoms following pulmonary vein (PV) CBA using implantable loop recorders (ILR) and patient-reported data. A total of 145 patients with highly symptomatic AF (EHRA score ≥ 2b) were consecutively enrolled and underwent primary PV CBA with simultaneous ILR implantation. Follow-up visits occurred at 3-, 6-, and 12-months post-ablation. Data were collected from patients’ symptom logs, ILR readings, and clinical events at each visit. Clinical efficacy was defined as the absence of AF recurrence based on patients’ symptom logs, while absolute efficacy was defined as the absence of AF detected by ILR. ILR detection served as the reference standard, and detection via patient symptom log was considered the test method. The absolute efficacy was 57,2% (n = 83). All cases of AF relapse were also reported by patients in their symptom logs. Agreement between patient-reported data and ILR data was substantial, with a κ statistic value of 0.98. The agreement between patient-reported data and ILR data showed a κ statistic value of 0.98. CBA using second-generation cryoballoon does not significantly alter AF symptom perception in highly symptomatic patients. Cardiac rhythm in these patients might be effectively monitored through symptom logs, ECGs, or Holter monitoring. ClinicalTrials.gov NCT03587181, SubstrateAF study, first posted date July 16, 2018.
- 26 September 2025
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 25 (1) , 1-6
Open AccessDoes cryoballoon ablation affect the symptom severity of atrial fibrillation? Insights from 12-months continuous cardiac monitoring
Most data on asymptomatic atrial fibrillation (AF) recurrence following catheter ablation primarily derive from studies on radiofrequency ablation (RFA). Our previous study with a small sample size revealed no significant difference in AF freedom rates detected via patient history, ECG, Holter monitoring, and continuous cardiac monitoring in the cryoballoon ablation (CBA) group. This study aims to evaluate alterations in AF symptoms following pulmonary vein (PV) CBA using implantable loop recorders (ILR) and patient-reported data. A total of 145 patients with highly symptomatic AF (EHRA score ≥ 2b) were consecutively enrolled and underwent primary PV CBA with simultaneous ILR implantation. Follow-up visits occurred at 3-, 6-, and 12-months post-ablation. Data were collected from patients’ symptom logs, ILR readings, and clinical events at each visit. Clinical efficacy was defined as the absence of AF recurrence based on patients’ symptom logs, while absolute efficacy was defined as the absence of AF detected by ILR. ILR detection served as the reference standard, and detection via patient symptom log was considered the test method. The absolute efficacy was 57,2% (n = 83). All cases of AF relapse were also reported by patients in their symptom logs. Agreement between patient-reported data and ILR data was substantial, with a κ statistic value of 0.98. The agreement between patient-reported data and ILR data showed a κ statistic value of 0.98. CBA using second-generation cryoballoon does not significantly alter AF symptom perception in highly symptomatic patients. Cardiac rhythm in these patients might be effectively monitored through symptom logs, ECGs, or Holter monitoring. ClinicalTrials.gov NCT03587181, SubstrateAF study, first posted date July 16, 2018.
- 28 July 2025
- Published by Media Sphere Publishing Group in Russian Journal of Preventive Medicine
- Vol. 28 (7)
Atrial fibrillation recurrences after catheter treatment and laboratory markers: is there a correlation?
Objective. To study the relationship between the results of catheter-based treatment (CBT) of atrial fibrillation (AF) and laboratory markers — titers of antibodies to the myocardium and the level of NT-proBNP. Materials and methods. The study included 197 patients with paroxysmal and persistent forms of AF without gross structural disorders of the heart were observed, who underwent cryoballoon ablation of the pulmonary vein ostia and had simultaneously implanted with a loop electrocardiogram recorder (Medtronic Reveal XT). Prior to surgery, blood was sampled, followed by biobanking. The patients returned for an outpatient visit 3, 6, and 12 months after the procedure. If the loop recorder showed a recurrence of AF, the patient was referred for a second electrophysiological examination to evaluate the integrity of the muscular sleeve of the pulmonary veins. In the case of repeated catheter-based surgery, patients were followed up according to a similar schedule and principle. Results. According to the results of this observation, patients were divided into two groups: patients without recurrence of AF after the first or second catheter-based procedure (venous AF) and patients with recurrence of AF after two catheter-based interventions, despite the achieved isolation of the pulmonary veins as a result of one or two operations (non-venous AF). Then, the laboratory data were analyzed to determine the relationship between them and outcomes of surgical treatment. No relationship was found between antimyocardial antibody titers and CBT outcomes. An association between NT-proBNP and CBT outcomes was revealed. Conclusion. Due to the lack of correlation between myocardial antibody titers and the outcomes of cryoballoon ablation of pulmonary veins in patients with atrial fibrillation, further studies and the search for new predictors of treatment outcomes are necessary. Patients with elevated NT-proBNP levels (more than 375 pg/mL) were 4.125 times more likely to relapse. The new findings help better understand the etiology and pathogenesis of atrial fibrillation. It is crucial to improve the selection of patients for catheter-based treatment and to facilitate the choice of management approach.
- 28 July 2025
- Published by Media Sphere Publishing Group in Russian Journal of Preventive Medicine
- Vol. 28 (7)
Atrial fibrillation recurrences after catheter treatment and laboratory markers: is there a correlation?
Objective. To study the relationship between the results of catheter-based treatment (CBT) of atrial fibrillation (AF) and laboratory markers — titers of antibodies to the myocardium and the level of NT-proBNP. Materials and methods. The study included 197 patients with paroxysmal and persistent forms of AF without gross structural disorders of the heart were observed, who underwent cryoballoon ablation of the pulmonary vein ostia and had simultaneously implanted with a loop electrocardiogram recorder (Medtronic Reveal XT). Prior to surgery, blood was sampled, followed by biobanking. The patients returned for an outpatient visit 3, 6, and 12 months after the procedure. If the loop recorder showed a recurrence of AF, the patient was referred for a second electrophysiological examination to evaluate the integrity of the muscular sleeve of the pulmonary veins. In the case of repeated catheter-based surgery, patients were followed up according to a similar schedule and principle. Results. According to the results of this observation, patients were divided into two groups: patients without recurrence of AF after the first or second catheter-based procedure (venous AF) and patients with recurrence of AF after two catheter-based interventions, despite the achieved isolation of the pulmonary veins as a result of one or two operations (non-venous AF). Then, the laboratory data were analyzed to determine the relationship between them and outcomes of surgical treatment. No relationship was found between antimyocardial antibody titers and CBT outcomes. An association between NT-proBNP and CBT outcomes was revealed. Conclusion. Due to the lack of correlation between myocardial antibody titers and the outcomes of cryoballoon ablation of pulmonary veins in patients with atrial fibrillation, further studies and the search for new predictors of treatment outcomes are necessary. Patients with elevated NT-proBNP levels (more than 375 pg/mL) were 4.125 times more likely to relapse. The new findings help better understand the etiology and pathogenesis of atrial fibrillation. It is crucial to improve the selection of patients for catheter-based treatment and to facilitate the choice of management approach.
- Open Access
- 8 June 2023
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 22 (5) , 3545
Value of morphological and laboratory markers in predicting the effectiveness of cryoballoon pulmonary vein isolation in atrial fibrillation
Aim. To determine the clinical, morphological, and biochemical predictors of substrate-specific, non-vein-dependent atrial fibrillation (AF) by morphological and immunological examinations in patients with recurrent AF after pulmonary vein (PV) isolation.Material and methods. The study included 100 people (58 men and 42 women) with paroxysmal (n=89) and persistent (n=11) AF with a mean age of 58,2±9,4 years. After the primary operation, 15 people withdrew from the study due to refusal of reintervention, and 1 person withdrew due to suppuration of loop recorder bed and its explantation. A total of 100 patients underwent primary cryoballoon PV isolation with myocardial biopsy from the interventricular and interatrial septa, while 60 patients had subsequent hematoxylin-eosin and Van Gieson stains. Also, 100 patients were simultaneously implanted with ECG loop recorders for AF monitoring and blood was taken (before the intervention) for subsequent analysis of inflammation markers and antimyocardial antibodies. Patients underwent clinical observation during the year (visits after 3, 6, 12 months). Patients with relapses were referred for repeat electrophysiological examination and segmental ablation if PV ruptures were detected. After repeated intervention, the follow-up period was extended for a year with the same schedule of visits. According Two groups of patients were formed: without relapses (vein-dependent AF, group I) and with relapses (non-vein-dependent AF, group II), despite the achieved PV isolation as a result of 1 or 2 operations.Results. An analysis of morphological changes showed that an increase in AF recurrence risk by an average of 6,14 times (95% confidence interval: 1,14-47,6 (p=0,0462)) is associated with stage 2 interventricular septal fibrosis. Lymphocyte infiltration of the interventricular septum was associated with higher AF recurrence by an average of 9 times (95% confidence interval: 0,89-95,37) (p=0,0519).Among the laboratory parameters, a significantly higher concentration of the N-terminal pro-brain natriuretic peptide and a significantly lower concentration of antimyocardial antibodies were found in the group of patients with recurrent AF after LV isolation (p=0,0101).Conclusion. Inflammatory myocardium changes are an important link in the pathogenesis of AF and are associated with its recurrence.
- 8 June 2023
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 22 (5) , 3545
Open AccessValue of morphological and laboratory markers in predicting the effectiveness of cryoballoon pulmonary vein isolation in atrial fibrillation
Aim. To determine the clinical, morphological, and biochemical predictors of substrate-specific, non-vein-dependent atrial fibrillation (AF) by morphological and immunological examinations in patients with recurrent AF after pulmonary vein (PV) isolation.Material and methods. The study included 100 people (58 men and 42 women) with paroxysmal (n=89) and persistent (n=11) AF with a mean age of 58,2±9,4 years. After the primary operation, 15 people withdrew from the study due to refusal of reintervention, and 1 person withdrew due to suppuration of loop recorder bed and its explantation. A total of 100 patients underwent primary cryoballoon PV isolation with myocardial biopsy from the interventricular and interatrial septa, while 60 patients had subsequent hematoxylin-eosin and Van Gieson stains. Also, 100 patients were simultaneously implanted with ECG loop recorders for AF monitoring and blood was taken (before the intervention) for subsequent analysis of inflammation markers and antimyocardial antibodies. Patients underwent clinical observation during the year (visits after 3, 6, 12 months). Patients with relapses were referred for repeat electrophysiological examination and segmental ablation if PV ruptures were detected. After repeated intervention, the follow-up period was extended for a year with the same schedule of visits. According Two groups of patients were formed: without relapses (vein-dependent AF, group I) and with relapses (non-vein-dependent AF, group II), despite the achieved PV isolation as a result of 1 or 2 operations.Results. An analysis of morphological changes showed that an increase in AF recurrence risk by an average of 6,14 times (95% confidence interval: 1,14-47,6 (p=0,0462)) is associated with stage 2 interventricular septal fibrosis. Lymphocyte infiltration of the interventricular septum was associated with higher AF recurrence by an average of 9 times (95% confidence interval: 0,89-95,37) (p=0,0519).Among the laboratory parameters, a significantly higher concentration of the N-terminal pro-brain natriuretic peptide and a significantly lower concentration of antimyocardial antibodies were found in the group of patients with recurrent AF after LV isolation (p=0,0101).Conclusion. Inflammatory myocardium changes are an important link in the pathogenesis of AF and are associated with its recurrence.
- Open Access
- 7 October 2021
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 21 (1) , 1-8
The predictive role of early recurrences of atrial arrhythmias after pulmonary vein cryoballoon ablation. Is blanking period an outdated concept? Insights from 12-month continuous cardiac monitoring
Background: Early recurrences of atrial arrhythmias (ERAA) after atrial fibrillation (AF) catheter ablation do not predict procedural failure. A well-demarcated homogeneous lesion delivered by cryoballoon is less arrhythmogenic, and the recommended three-months blanking period may not refer to cryoballoon ablation (CBA). Objective: We aimed to evaluate the predictive role of ERAA after second-generation CBA using an implantable loop recorder. Methods: This prospective observational study enrolled 100 patients (58 males, median age 58) with paroxysmal/persistent AF undergoing pulmonary vein (PV) CBA using second-generation cryoballoon with simultaneous ECG loop recorder implantation. The duration of follow-up was 12 months, with scheduled visits at 3, 6 and 12 months. Results: 99 patients from 100 completed the 12-month follow-up period. ERAA occurred in 31.3 % of patients. 83.9 % of patients with ERAA also developed late recurrences. The 12-month freedom from AF in patients with ERAA was significantly lower than in those without ERAA (p < 0.0001). Non-paroxysmal AF and longer arrhythmia history were associated with increased risk of both early (HR 3.27; 95 % CI 1.32–8.08; p = 0.010 and HR 1.0147; 95 % CI 1.008–1.086; p = 0.015, respectively) and late recurrences (HR 3.89; 95 % CI 1.67–9.04; p = 0.002 and HR 1.0142; 95 % CI 1.007–1.078; p = 0.019, respectively) of AF. ERAA were another predictor for procedural failure (HR 15.2; 95 % CI (6.42–35.99; p = 0.019). Conclusions: ERAA occurred in the third of the patients after PV second-generation CBA and are strongly associated with procedural failure. Longer duration of AF history and persistent AF are independent predictors of AF’s early and late recurrence.
- 7 October 2021
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 21 (1) , 1-8
Open AccessThe predictive role of early recurrences of atrial arrhythmias after pulmonary vein cryoballoon ablation. Is blanking period an outdated concept? Insights from 12-month continuous cardiac monitoring
Background: Early recurrences of atrial arrhythmias (ERAA) after atrial fibrillation (AF) catheter ablation do not predict procedural failure. A well-demarcated homogeneous lesion delivered by cryoballoon is less arrhythmogenic, and the recommended three-months blanking period may not refer to cryoballoon ablation (CBA). Objective: We aimed to evaluate the predictive role of ERAA after second-generation CBA using an implantable loop recorder. Methods: This prospective observational study enrolled 100 patients (58 males, median age 58) with paroxysmal/persistent AF undergoing pulmonary vein (PV) CBA using second-generation cryoballoon with simultaneous ECG loop recorder implantation. The duration of follow-up was 12 months, with scheduled visits at 3, 6 and 12 months. Results: 99 patients from 100 completed the 12-month follow-up period. ERAA occurred in 31.3 % of patients. 83.9 % of patients with ERAA also developed late recurrences. The 12-month freedom from AF in patients with ERAA was significantly lower than in those without ERAA (p < 0.0001). Non-paroxysmal AF and longer arrhythmia history were associated with increased risk of both early (HR 3.27; 95 % CI 1.32–8.08; p = 0.010 and HR 1.0147; 95 % CI 1.008–1.086; p = 0.015, respectively) and late recurrences (HR 3.89; 95 % CI 1.67–9.04; p = 0.002 and HR 1.0142; 95 % CI 1.007–1.078; p = 0.019, respectively) of AF. ERAA were another predictor for procedural failure (HR 15.2; 95 % CI (6.42–35.99; p = 0.019). Conclusions: ERAA occurred in the third of the patients after PV second-generation CBA and are strongly associated with procedural failure. Longer duration of AF history and persistent AF are independent predictors of AF’s early and late recurrence.
- Open Access
- 28 March 2021
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 26 (2) , 4283
Myocardial morphological changes and pulmonary vein catheter ablation efficacy in patients with atrial fibrillation
Aim. To study the association between morphological changes and comorbidities and atrial fibrillation (AF) catheter ablation efficacy, and to evaluate morphological predictors of AF recurrence in patients with durable pulmonary vein isolation (PVI) after catheter intervention.Material and methods. Fifty-four patients with paroxysmal/persistent AF without severe structural heart disease were enrolled in this study who underwent primary pulmonary vein cryoballoon ablation (CBA) with simultaneous implantation of an electrocardiogram loop recorder (Medtronic Reveal XT) and interatrial/interventricular septum biopsy. The follow-up duration was 12 months with scheduled 3, 6 and 12 month visits. Patients with recurrent AF were referred for redo procedure, where the PVI durability was assessed. The follow-up duration after the second procedure was also 12 months. The patients were divided into two groups: patients without recurrent AF and patients with recurrent AF after two catheter interventions.Results. In interventricular septum biopsy samples we found the morphological criteria of myocarditis in 70% of the patients (n=34). Individual morphological changes were detected in all patients. The most common types were cardiomyocyte hypertrophy — 98,1% (n= 52), overcrossing of cardiomyocytes — 77,4% (n=41) and lymphohistiocytic infiltration of the interstitium by more than 14 cells — 75,5% (n=40). Patients with persistent AF were significantly more likely to have endothelial cell swelling (55% vs 45%, p=0,022). Interstitial tissue edema was the only morphological parameter significantly associated with AF recurrence (p=0,03).Conclusion. In patients with AF and no structural heart disease who underwent drug-resistant AF cryoballoon ablation, morphological changes in the myocardium of the atria and ventricles are detected in 100% of cases. The predominant biopsy diagnosis is myocarditis. Morphological signs of the inflammatory process activity, as interstitial tissue edema are associated with the high incidence of non-venous AF. Further preoperative evaluation is needed to identify patients with non-venous atrial fibrillation, which will increase the effectiveness of interventional approach.
- 28 March 2021
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 26 (2) , 4283
Open AccessMyocardial morphological changes and pulmonary vein catheter ablation efficacy in patients with atrial fibrillation
Aim. To study the association between morphological changes and comorbidities and atrial fibrillation (AF) catheter ablation efficacy, and to evaluate morphological predictors of AF recurrence in patients with durable pulmonary vein isolation (PVI) after catheter intervention.Material and methods. Fifty-four patients with paroxysmal/persistent AF without severe structural heart disease were enrolled in this study who underwent primary pulmonary vein cryoballoon ablation (CBA) with simultaneous implantation of an electrocardiogram loop recorder (Medtronic Reveal XT) and interatrial/interventricular septum biopsy. The follow-up duration was 12 months with scheduled 3, 6 and 12 month visits. Patients with recurrent AF were referred for redo procedure, where the PVI durability was assessed. The follow-up duration after the second procedure was also 12 months. The patients were divided into two groups: patients without recurrent AF and patients with recurrent AF after two catheter interventions.Results. In interventricular septum biopsy samples we found the morphological criteria of myocarditis in 70% of the patients (n=34). Individual morphological changes were detected in all patients. The most common types were cardiomyocyte hypertrophy — 98,1% (n= 52), overcrossing of cardiomyocytes — 77,4% (n=41) and lymphohistiocytic infiltration of the interstitium by more than 14 cells — 75,5% (n=40). Patients with persistent AF were significantly more likely to have endothelial cell swelling (55% vs 45%, p=0,022). Interstitial tissue edema was the only morphological parameter significantly associated with AF recurrence (p=0,03).Conclusion. In patients with AF and no structural heart disease who underwent drug-resistant AF cryoballoon ablation, morphological changes in the myocardium of the atria and ventricles are detected in 100% of cases. The predominant biopsy diagnosis is myocarditis. Morphological signs of the inflammatory process activity, as interstitial tissue edema are associated with the high incidence of non-venous AF. Further preoperative evaluation is needed to identify patients with non-venous atrial fibrillation, which will increase the effectiveness of interventional approach.
- Open Access
- 14 November 2020
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 19 (5) , 2579
Relationship between serum inflammatory markers and recurrent atrial fibrillation in patients undergoing pulmonary vein isolation
Изучение взаимосвязи маркеров воспаления в сыворотке крови и рецидивирования фибрилляции предсердий у пациентов, перенесших катетерную изоляцию легочных вен
- 14 November 2020
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 19 (5) , 2579
Open AccessRelationship between serum inflammatory markers and recurrent atrial fibrillation in patients undergoing pulmonary vein isolation
Изучение взаимосвязи маркеров воспаления в сыворотке крови и рецидивирования фибрилляции предсердий у пациентов, перенесших катетерную изоляцию легочных вен
- Open Access
- 18 August 2019
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- No. 7
The role of inflammatory theory in the pathogenesis of atrial fibrillation
- 18 August 2019
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- No. 7
Open AccessThe role of inflammatory theory in the pathogenesis of atrial fibrillation